This article is available to subscribers. Subscribe now. Already have an account? Sign in

EditorialFree Preview

E-Cigarettes to Assist with Smoking Cessation

List of authors.
  • Belinda Borrelli, Ph.D.,
  • and George T. O’Connor, M.D.

This article has no abstract; the first 100 words appear below.

The prevalence of tobacco smoking in the United States has declined to 14.0% but still exceeds 25% among high-risk subgroups.1,2 Electronic cigarettes (e-cigarettes) are not approved by the Food and Drug Administration (FDA) for smoking cessation, but Americans trying to quit smoking use these products more frequently than FDA-approved cessation aids.3 Comparative-effectiveness trials are needed to learn whether smokers have a better chance of quitting with e-cigarettes. Previous trials have had methodologic shortcomings, used first-generation e-cigarettes, or did not assess long-term outcomes. Hajek et al.4 now report in the Journal the results of a multicenter, pragmatic, randomized trial of e-cigarettes, . . .

Continue reading this article

Select an option below:

Register to get 3 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this editorial at NEJM.org.

This editorial was published on January 30, 2019, at NEJM.org.

Author Affiliations

From the Center for Behavioral Science Research, Department of Health Policy and Health Services Research, Henry M. Goldman School of Dental Medicine, Boston University (B.B.), and the Pulmonary Center, Boston University School of Medicine, and Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston Medical Center (G.T.O.) — all in Boston.